Portfolio company
Asher Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
The company develops cis-targeted immunotherapies that selectively activate specific immune cells to treat patients with cancer and other diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Asher Biotherapeutics
This biotechnology company develops targeted immunotherapies for patients with cancer, infectious diseases and autoimmune conditions.
ArsenalBio
The company develops programmable T cell therapies for patients with solid tumours and autoimmune diseases.
D3 Bio
This biotechnology company develops precision medicines and oncology therapeutics for patients with cancer and immunological conditions.
Appia Bio
This company develops engineered allogeneic cell therapies from hematopoietic stem cells for cancer patients.
HI-Bio
This biotechnology company develops targeted therapies for patients suffering from severe immune-mediated diseases.
Athernal Bio
The company develops targeted immunotherapies for patients with high-risk clonal haematopoiesis to prevent the development of blood cancers.
Orca Bio
This company develops high-precision allogeneic cell therapies to treat patients with blood cancers and autoimmune diseases by replacing diseased immune systems with donor cells.
Attovia Therapeutics
The company develops biparatopic biologics to treat patients with immune-mediated diseases and cancer through a modular protein design platform.